Under the persistent combination of these two stimuli, a condition probably unique to SLE patients, the CD8+ T cells displayed increased PARP gene expression associated with enhanced NAD+ consumption, reduced mitochondrial oxidative capacity and decreased survival (Fig. 7). The gene discussed is CD8A; the disease is systemic lupus erythematosus.